LU75242A1 - - Google Patents
Info
- Publication number
- LU75242A1 LU75242A1 LU75242A LU75242A LU75242A1 LU 75242 A1 LU75242 A1 LU 75242A1 LU 75242 A LU75242 A LU 75242A LU 75242 A LU75242 A LU 75242A LU 75242 A1 LU75242 A1 LU 75242A1
- Authority
- LU
- Luxembourg
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7519960A FR2315277A1 (fr) | 1975-06-25 | 1975-06-25 | Nouveaux derives pentacycliques, leur preparation et les compositions qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
LU75242A1 true LU75242A1 (fr) | 1978-01-18 |
Family
ID=9157046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU75242A LU75242A1 (fr) | 1975-06-25 | 1976-06-25 |
Country Status (17)
Country | Link |
---|---|
US (1) | US4138489A (fr) |
JP (1) | JPS6039679B2 (fr) |
AU (1) | AU496905B2 (fr) |
BE (1) | BE843215A (fr) |
CH (1) | CH616425A5 (fr) |
DE (1) | DE2627190A1 (fr) |
DK (1) | DK285576A (fr) |
ES (1) | ES449209A1 (fr) |
FR (1) | FR2315277A1 (fr) |
GB (1) | GB1543807A (fr) |
HU (1) | HU174882B (fr) |
IE (1) | IE43138B1 (fr) |
IL (1) | IL49864A0 (fr) |
LU (1) | LU75242A1 (fr) |
NL (1) | NL7606884A (fr) |
SE (1) | SE420730B (fr) |
ZA (1) | ZA763779B (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA786426B (en) * | 1977-11-25 | 1979-10-31 | Scras | New indulo(2,3-a)quinolizidines,preparation and therapeutic use |
US4428877A (en) | 1978-07-12 | 1984-01-31 | Richter Gedeon Vegyeszeti Gyar Rt. | Cis-10-bromo-E-homoeburnanes |
JPH0523116Y2 (fr) * | 1988-07-29 | 1993-06-14 | ||
IT1248881B (it) * | 1989-06-21 | 1995-01-30 | Richter Gedeon Vegyeszet | Derivati diesteri di ottaidro-indolo/2,3-a/tetraidropiramil/2,3-c/ chinolizina racemici ed otticamente attivi e procedimento per la loro preparazione |
ITRM20010356A1 (it) * | 2001-06-21 | 2002-12-23 | Sigma Tau Ind Farmaceuti | "5-alogeno derivati della triptamina utili come ligandi del recettore5-ht6 e/o 5-ht7 della serotonina. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3536725A (en) * | 1967-11-22 | 1970-10-27 | Miles Lab | Cyanoethylated derivatives of 2,3,4,6,7,12-hexahydroindolo(2,3-alpha)-quinolizine |
FR2168853B1 (fr) * | 1972-01-24 | 1975-04-25 | Centre Etd Ind Pharma |
-
1975
- 1975-06-25 FR FR7519960A patent/FR2315277A1/fr active Granted
-
1976
- 1976-06-14 CH CH751576A patent/CH616425A5/fr not_active IP Right Cessation
- 1976-06-16 DE DE19762627190 patent/DE2627190A1/de not_active Ceased
- 1976-06-21 BE BE168153A patent/BE843215A/fr not_active IP Right Cessation
- 1976-06-21 IE IE1337/76A patent/IE43138B1/en unknown
- 1976-06-22 IL IL49864A patent/IL49864A0/xx unknown
- 1976-06-23 GB GB26130/76A patent/GB1543807A/en not_active Expired
- 1976-06-23 SE SE7607231A patent/SE420730B/xx unknown
- 1976-06-24 HU HU76AE468A patent/HU174882B/hu unknown
- 1976-06-24 ZA ZA763779A patent/ZA763779B/xx unknown
- 1976-06-24 NL NL7606884A patent/NL7606884A/xx not_active Application Discontinuation
- 1976-06-24 AU AU15236/76A patent/AU496905B2/en not_active Expired
- 1976-06-24 DK DK285576A patent/DK285576A/da not_active Application Discontinuation
- 1976-06-25 LU LU75242A patent/LU75242A1/xx unknown
- 1976-06-25 ES ES449209A patent/ES449209A1/es not_active Expired
- 1976-06-25 US US05/700,028 patent/US4138489A/en not_active Expired - Lifetime
- 1976-06-25 JP JP51074537A patent/JPS6039679B2/ja not_active Expired
Also Published As
Publication number | Publication date |
---|---|
JPS5217488A (en) | 1977-02-09 |
BE843215A (fr) | 1976-12-21 |
DE2627190A1 (de) | 1977-01-20 |
SE7607231L (sv) | 1976-12-26 |
FR2315277B1 (fr) | 1979-08-10 |
SE420730B (sv) | 1981-10-26 |
NL7606884A (nl) | 1976-12-28 |
GB1543807A (en) | 1979-04-04 |
CH616425A5 (fr) | 1980-03-31 |
FR2315277A1 (fr) | 1977-01-21 |
HU174882B (hu) | 1980-04-28 |
AU1523676A (en) | 1978-01-05 |
AU496905B2 (en) | 1978-11-09 |
JPS6039679B2 (ja) | 1985-09-06 |
IL49864A0 (en) | 1976-08-31 |
IE43138B1 (en) | 1980-12-31 |
US4138489A (en) | 1979-02-06 |
ES449209A1 (es) | 1977-07-16 |
IE43138L (en) | 1976-12-25 |
DK285576A (da) | 1976-12-26 |
ZA763779B (en) | 1977-06-29 |